These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22768898)

  • 1. Noninvasive monitoring of glucose levels: is exhaled breath the answer?
    Roberts K; Jaffe A; Verge C; Thomas PS
    J Diabetes Sci Technol; 2012 May; 6(3):659-64. PubMed ID: 22768898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis.
    Baker EH; Clark N; Brennan AL; Fisher DA; Gyi KM; Hodson ME; Philips BJ; Baines DL; Wood DM
    J Appl Physiol (1985); 2007 May; 102(5):1969-75. PubMed ID: 17303703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide.
    Ho LP; Innes JA; Greening AP
    Thorax; 1998 Aug; 53(8):680-4. PubMed ID: 9828856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of pancreatic function in the breath.
    Roberts K; Liu I; Jaffe A; Verge CF; Thomas PS
    J Breath Res; 2014 Nov; 8(4):046009. PubMed ID: 25417673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring in cystic fibrosis - A practical guide.
    Chan CL; Ode KL; Granados A; Moheet A; Moran A; Hameed S
    J Cyst Fibros; 2019 Oct; 18 Suppl 2():S25-S31. PubMed ID: 31679725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole as a new tentative marker in exhaled breath for non-invasive blood glucose monitoring of diabetic subjects.
    Fink H; Maihöfer T; Bender J; Schulat J
    J Breath Res; 2022 Jan; 16(2):. PubMed ID: 34942609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring states of altered carbohydrate metabolism via breath analysis: are times ripe for transition from potential to reality?
    Dowlaty N; Yoon A; Galassetti P
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):466-72. PubMed ID: 23739629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive glucose detection in exhaled breath condensate.
    Tankasala D; Linnes JC
    Transl Res; 2019 Nov; 213():1-22. PubMed ID: 31194942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
    Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
    J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of breath and skin analysis for monitoring blood glucose concentration in diabetes.
    Turner C
    Expert Rev Mol Diagn; 2011 Jun; 11(5):497-503. PubMed ID: 21707458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensors for Enhanced Detection of Acetone as a Potential Tool for Noninvasive Diabetes Monitoring.
    Rydosz A
    Sensors (Basel); 2018 Jul; 18(7):. PubMed ID: 30012960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose self-monitoring. Part 3: smart monitoring.
    Dubois W
    Diabetes Self Manag; 2014 Oct; 31(5):14, 17-9. PubMed ID: 25322655
    [No Abstract]   [Full Text] [Related]  

  • 14. Exhaled Breath Condensate (EBC): Is It a Viable Source of Biomarkers for Lung Diseases?
    Patsiris S; Exarchos T; Vlamos P
    Adv Exp Med Biol; 2020; 1195():13-18. PubMed ID: 32468452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled breath condensate biomarkers in COPD.
    Borrill ZL; Roy K; Singh D
    Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved predictive models for plasma glucose estimation from multi-linear regression analysis of exhaled volatile organic compounds.
    Lee J; Ngo J; Blake D; Meinardi S; Pontello AM; Newcomb R; Galassetti PR
    J Appl Physiol (1985); 2009 Jul; 107(1):155-60. PubMed ID: 19423833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath condensate pH decreases following oral glucose tolerance test.
    Bikov A; Pako J; Montvai D; Kovacs D; Koller Z; Losonczy G; Horvath I
    J Breath Res; 2015 Dec; 9(4):047112. PubMed ID: 26669903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Examination of exhaled breath condensate in cystic fibrosis].
    Fila L; Musil J
    Cas Lek Cesk; 2010; 149(4):173-7. PubMed ID: 20518250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive breath monitoring with eNose does not improve glucose diagnostics in critically ill patients in comparison to continuous glucose monitoring in blood.
    Leopold JH; Bos LDJ; Colombo C; Sterk PJ; Schultz MJ; Abu-Hanna A
    J Breath Res; 2017 Apr; 11(2):026002. PubMed ID: 28260695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis.
    Colombo C; Faelli N; Tirelli AS; Fortunato F; Biffi A; Claut L; Cariani L; Daccò V; Prato R; Conese M
    Int J Immunopathol Pharmacol; 2011; 24(2):423-32. PubMed ID: 21658316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.